CarLotz (LOTZ) began trading on the Nasdaq on Fri 22 Jan 21

 CarLotz, Inc. operates as a consignment-to-retail used consignment store.

• Sector(s): Consumer Cyclical
• Industry: Auto & Truck Dealerships
• Full Time Employees: 166
• 8 locations and online sales
• Headquartered in Richmond, Virginia
• http://www.carlotz.com

 

August 09, 2022:  CarLotz (Nasdaq: LOTZ) to merge with Shift Technologies, Inc. (Nasdaq: SFT), a leading end-to-end ecommerce platform for buying and selling used cars.

October 6, 2023, Shift Technologies announced its intentions to file for Chapter 11 bankruptcy. 

Went public through a merger with a Nasdaq-listed special purpose acquisition (SPAC) Acamar Partners Acquisition Corp., a Miami, Florida-based SPAC that was formed in 2018 and went public with a $300 million IPO in 2019.  Acamar Partners was led by private equity investors Juan Carlos Torres Carretero and Luis Ignacio Solorzano Aizpuru.

CarLotz was the third major U.S. online car seller to go public this past year after Vroom (VRM) and Shift Technologies Inc (SFT).

Online sales only account for around 1% of the roughly $840 billion Americans spend annually on used cars. But after numerous U.S. states went into COVID-19 lockdowns, the advantage of socially distant online sales has come into focus.

CarLotz co-founders Michael Bor (left), Will Boland (center) and Aaron Montgomery (right). 

CarLotz founders, from left, Michael Bor, Aaron Montgomery and Will Boland.

Codiak BioSciences (CDAK) began trading on the Nasdaq on Wed 14 Oct 20

 Update: Mar 27, 2023 — Codiak has voluntarily filed for Chapter 11 bankruptcy.

• Codiak BioSciences priced 5.5 mln share IPO at $15, the mid-point of the $14-$16 expected price range, for gross proceeds of ~$82.5M.
• Underwriters' over-allotment is an additional 825K shares.
• Closing date is October 16.
• Goldman Sachs, Evercore ISI and William Blair are acting as joint book-running managers. Wedbush PacGrow is lead manager.

The Cambridge, Massachusetts-based biotech emerged in 2015 with $31 million in VC funding and ex-Biogen R&D chief Doug Williams at the helm. It picked up another $61 million in a series B round just months later and, in 2017, topped that up with a $76.5 million series C.

In April 2019, Codiak was ready to hit the Street, filing to raise up to $86 million in its IPO. It withdrew that attempt two months later and refiled in September this year.

About Codiak

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.

Sector(s): Healthcare

Industry: Biotechnology

Full Time Employees: 101

HQ: Cambridge, MA United States

http://www.codiakbio.com

Party City (PRTY) began trading on the NYSE on 16 April 2015

• On January 17, 2023, Party City filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court to restructure its debt (around $1.4–$1.5 billion pre-bankruptcy). This was aimed at shedding debt while continuing operations.
• The original PRTY shares were delisted in 2023 and now trade over-the-counter (OTC) under PRTYQ.

Description

Party City Holdco Inc. is a designer, manufacturer and distributor of decorated party supplies. The Company operates in two segments: Retail and Wholesale. The Company, through Retail segment, engages in the sale of merchandise through party goods stores and online through its e-commerce Websites, including www.PartyCity.com. The Company, through Wholesale segment, engages in the sale of Amscan, Designware, Anagram, Costumes USA and other party supplies. Its tableware products include plastic plates, paper plates, plastic cups and paper cups, among others. The Company's favors, stationery and other products include party favors, gift bags, gift wrap, invitations, bows and stationery. Its decorations products include latex balloons, pinatas, crepes, and flags and banners, among others. The Company's metallic balloons products include bouquets, standard 18 inch sing-a-tune, supershapes and weights. Its Costumes and Accessories products include costumes, other wearables and wigs.

Address

80 Grasslands Rd
ELMSFORD, NY 10523-1100
United States

Key stats and ratios

	Q4 (Dec '14)	2014
Net profit margin	9.82%	2.47%
Operating margin	19.67%	10.90%
EBITD margin	-	14.56%
Return on average assets	9.16%	1.67%
Return on average equity	65.06%	11.20%
Employees	7,313

Celladon (CLDN) : 4-month performance

• March 22, 2016— Celladon changed its name to Eiger BioPharmaceuticals (EIGR) (March 23, 2016)
• Apr 2, 2024 — Eiger BioPharmaceuticals declared bankruptcy and sold all its assets as the company wound down operations.

Ticker: CLDN

Delivery Agent eyes $100m IPO

Update Sep 16, 2016: Delivery Agent, a company that helps entertainment and sports operations sell products online, filed for chapter 11 bankruptcy protection Thursday, after hopes of an initial public offering of stock fell through.

****

Commerce technology company Delivery Agent, which sells products such as a $30,000 Game of Thrones replica iron throne, is reportedly looking to raise around $100m via an IPO next year.

The venture capital-backed company has hired banks Deutsche Bank and Credit Suisse to manage the IPO, which is expected to take place in mid-2014, said Reuters, citing two sources familiar with the matter.

Delivery Agent enables viewers to purchase products they see on TV shows. Its partners include Fox, CBS, HBO, Showtime, AT&T, Visa, and PepsiCo.

The company is backed by Bessember Venture Partners, Samsung, Cardinal Venture Capital, Worldwide Technology Partners and Liberty Global and Intel Capital, which led a $35.5m Series E round for the company in 2011.

Avianca (AVH) began trading on the NYSE on 6 November 2013

• On May 10, 2020, Avianca filed for Chapter 11 bankruptcy in a court in New York City, and liquidated its subsidiary Avianca Perú, becoming one of the major airlines to have filed for bankruptcy due to the COVID-19 pandemic crisis. Delisted from NYSE.

Executives and guest from Avianca, national airline of Colombia, fly in from Latin America to the NYSE to celebrate their company’s IPO, which began trading on the NYSE under the ticker symbol “AVH”. Today, the Colombian airline boasts about 140 planes, a fast-growing number of customers and flights to more than 100 cities, including Madrid and Buenos Aires.

The CEO of Avianca Fabio Villegas Ramirez ( C) celebrates their IPO at the New York Stock Exchange in New York, November 6, 2013.

Solazyme (SZYM) looks good today

• Solazyme officially changed its name to TerraVia Holdings Inc. in March 2016 with a redefined focus on food, nutrition, and personal care. As part of the change, the company stated that its previous fuel and industrial oil products and workings would operate under Solazyme Industrials.
• On August 2, 2017, TerraVia filed for bankruptcy protection under Chapter 11. The company announced a "stalking horse" offer from Corbion, N.V., a Netherlands food and biochemical company.  The offer values TerraVia's assets at $20 million.  By comparison, Solazyme's IPO raised over $197 million.

** weekly **